Glenmark Pharmaceuticals
GLENMARK.NS
£13.61
Share price
-2.94%
Change (1 day)
41.06%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt
Total debt on the balance sheet as of September 2024 : £0.16 Billion
According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is £0.16 Billion. A company’s total debt is the sum of all current and non-current debts.
Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | £0.11 B | -74.19% |
| 2023-03-31 | £0.45 B | 13.93% |
| 2022-03-31 | £0.39 B | -19.47% |
| 2021-03-31 | £0.49 B | -11.17% |
| 2020-03-31 | £0.55 B | 13.19% |
| 2019-03-31 | £0.49 B | -3.38% |
| 2018-03-31 | £0.50 B | -13% |
| 2017-03-31 | £0.58 B | 39.76% |
| 2016-03-31 | £0.41 B | 1.84% |
| 2015-03-31 | £0.41 B | 25.14% |
| 2014-03-31 | £0.32 B | -2.08% |
| 2013-03-31 | £0.33 B | 21.38% |
| 2012-03-31 | £0.27 B | -6.15% |
| 2011-03-31 | £0.29 B | 7% |
| 2010-03-31 | £0.27 B | -4.41% |
| 2009-03-31 | £0.28 B | 129.62% |
| 2008-03-31 | £0.12 B | 13.26% |
| 2007-03-31 | £0.11 B | 16.31% |
| 2006-03-31 | £95.04 M | 79.02% |
| 2005-03-31 | £53.09 M | 269.19% |
| 2004-03-31 | £14.38 M |